ArticleMaterials (Basel, Switzerland)2024
Simvastatin Efficacy on Endodontic Biofilms: An In Vitro Study.
Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Efficacy of Calcium Silicate-Based, Simvastatin, Levofloxacin and Calcium Hydroxide Intracanal Medicaments Against Mature Enterococcus faecalis Biofilm. An In Vitro Study.Australian endodontic journal : the journal of the Australian Society of Endodontology Inc · 2026Article
- Review
- Endodontic potential of eugenol againstJournal of oral biology and craniofacial researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The outcome of endodontic therapy is directly related to the control of infection. The aim of the study was to evaluate in vitro the efficacy of Simvastatin (SIM) and diclofenac (DC) solutions on endodontic biofilms.
methodsMature biofilms were grown on dentin specimens and put in contact with the solutions to determine their antibiofilm activity. To assess residual antimicrobial activity, the dentin samples were immersed for 5 min in the solutions before microbial infection for 3 weeks. The study groups were: (1) 8% SIM, (2) 4% SIM, (3) 4% DC, (4) 2.5% sodium hypochlorite (NaOCl), and (5) 0.9% saline solution (SS). Cell viability was evaluated by means of the adenosine triphosphate (ATP) assay and flow cytometry (FC). The data collected were analyzed with the ANOVA test using Welch's correction followed by the Games-Howell test. The level of statistical significance was
resultsAll study groups reduced the biofilms significantly with respect to the control. The highest reduction percentage was obtained by 2.5% NaOCl, followed by SIM 8% and 4%, without statistically significant differences. In terms of residual activity, the 4% DC solution obtained a higher percentage of dead cells.
conclusionSolutions of 4% and 8% SIM, and 4% Diclofenac, show antimicrobial and residual activity against multispecies endodontic biofilms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.